Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: SYNERGENE THERAPEUTICS INC
Awarding agency: Department of Defense / Defense Threat Reduction Agency
Funding agency: Department of Defense / Defense Threat Reduction Agency
Period of performance: 2020-07-07 to 2023-11-06
Current total value of award: $6047893.65
Description: APPLICATION OF A NANOCOMPLEX TECHNOLOGY TO THE ACTIVE PERMEATION OF THE BLOOD BRAIN BARRIER